Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
I would treat this as a credible, urgent safety signal, not as a finding that can wait six months for a completed regulatory submission. The estimate—liver failure in roughly 1 in 8,000 patients over five years—needs validation, but the outcome is severe and the current warning omits it.Read the full answer
48-Hour Action Plan: Drug Safety Crisis Response My Core Decision I will recommend full, proactive disclosure. Waiting is not a viable option. Here's why: Every day of delay adds approximately 22 patients exposed to an undisclosed risk Regulatory agencies treat delayed voluntary disclosure far more favorably than…Read the full answer